Original article

DOI: 10.1016/j.gastre.2022.11.010

Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes

Predicción de eventos clínicos por elasticidad hepática y enfermedad renal crónica por EHMet en pacientes con diabetes tipo 2

Descargar PDF

Jesús Rivera-Estebana,b,

Autor para correspondencia

jesusriveraest@gmail.com

Corresponding authors.

, Mònica Ponsa,b,c,1, Alejandra Planasd,e, Ramiro Manzano-Nuñeza, Cristina Hernándezb,d,e, Olga Simó-Servatd,e, Jordi Bañerasf,g, María José Solerh,i, Daniel Seronh,i, Anna Boixaderaj, Salvador Augustina,b,c,k, Rafael Simób,d,e, Ignacio Ferreira-Gonzálezb,f,g, Joan Genescàa,b,c,

Autor para correspondencia

joan.genesca@vallhebron.cat

Corresponding authors.

, Juan M. Pericàsa,b,c, on behalf of the PRECISED consortium 2

a Liver Unit, Vall d’Hebron Hospital Universitari, Vall d’Hebron Institut of Research (VHIR), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

b Universitat Autònoma de Barcelona, Bellaterra, Spain

c CIBEREHD, ISCIII, Madrid, Spain

d Diabetes and Metabolism Research Unit, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

e CIBERDEM, ISCIII, Madrid, Spain

f Cardiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Hospital Universitari, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain

g CIBERESP, ISCIII, Madrid, Spain

h Nephrology Department, Vall d’Hebron Research Institute, Vall d’Hebron Hospital, Barcelona, Spain

i REDinREN, ISCIII, Madrid, Spain

j Ophthalmology Department, Vall d’Hebron Research Institute, Vall d’Hebron Hospital, Autonomous University of Barcelona, Barcelona, Spain

k Therapeutic Area Cardio-Metabolism and Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany

Ver más

Ver resumen